Cutaneous squamous cell carcinoma that doesn’t reply to therapy with an immunotherapy known as a checkpoint inhibitor has no FDA-approved therapeutic alternate options. Replimune's lead program, an oncolytic virus, fell quick in a examine that hoped to offer sufferers one. The corporate remains to be pushing forward with its engineered virus for different types of pores and skin most cancers, […]
